|
GDPD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.071400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.766800E-01 |
| Normal-vs-Stage2 |
2.132000E-01 |
| Normal-vs-Stage3 |
9.001400E-01 |
| Normal-vs-Stage4 |
2.938400E-01 |
| Stage1-vs-Stage2 |
5.662200E-02 |
| Stage1-vs-Stage3 |
7.542000E-01 |
| Stage1-vs-Stage4 |
7.714300E-02 |
| Stage2-vs-Stage3 |
2.083200E-01 |
| Stage2-vs-Stage4 |
8.296800E-01 |
| Stage3-vs-Stage4 |
1.944800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.131600E-01 |
| Normal-vs-AfricanAmerican |
5.686600E-01 |
| Normal-vs-Asian |
5.674400E-01 |
| Caucasian-vs-AfricanAmerican |
4.870000E-01 |
| Caucasian-vs-Asian |
4.473000E-01 |
| AfricanAmerican-vs-Asian |
6.336400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.552200E-01 |
| Normal-vs-Female |
1.507990E-02 |
| Male-vs-Female |
6.610800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.803600E-01 |
| Normal-vs-Extreme_Weight |
1.624980E-01 |
| Normal-vs-Obese |
9.586000E-01 |
| Normal-vs-Extreme_Obese |
3.943000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.232200E-01 |
| Normal_Weight-vs-Obese |
7.286600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.074200E-01 |
| Extreme_Weight-vs-Obese |
2.429400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.295200E-01 |
| Obese-vs-Extreme_Obese |
3.901800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.417560E-01 |
| Normal-vs-Age(41-60Yrs) |
2.476800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.968400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.397360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.078800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.134100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.722100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.829900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.648500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.565600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.413400E-01 |
| Normal-VS-Type2 PRCC |
6.782800E-01 |
| Normal-VS-KIRP CIMP |
1.836400E-01 |
| Normal-VS-Unclassified PRCC |
3.952800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.658000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.360000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.142800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.572020E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.665800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.971800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.498800E-01 |
| Normal-vs-N1 |
4.047000E-01 |
| Normal-vs-N2 |
2.680800E-01 |
| N0-vs-N1 |
1.160200E-01 |
| N0-vs-N2 |
2.181400E-01 |
| N1-vs-N2 |
1.022790E-01 |
|
|
